D.E. Shaw & Co
IMCR icon

D.E. Shaw & Co’s Immunocore IMCR Stock Holding History

D.E. Shaw & Co’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Buy
335,191
+151,251
+82% +$4.89M 0.01% 1636
2025
Q4 		$6.38M Buy
+183,940
New +$6.49M ﹤0.01% 2106
2024
Q3 		– Sell
-19,515
Closed -$661K – 4692
2024
Q2 		$661K Sell
19,515
-120,579
-86% -$6.15M ﹤0.01% 3452
2024
Q1 		$9.11M Buy
140,094
+55,441
+65% +$3.8M 0.01% 1434
2023
Q4 		$5.78M Sell
84,653
-53,750
-39% -$2.79M 0.01% 1796
2023
Q3 		$7.18M Sell
138,403
-81,556
-37% -$4.83M 0.01% 1512
2023
Q2 		$13.2M Sell
219,959
-94,480
-30% -$5.39M 0.01% 1127
2023
Q1 		$15.5M Sell
314,439
-48,960
-13% -$2.75M 0.02% 1051
2022
Q4 		$20.7M Buy
363,399
+230,897
+174% +$13M 0.02% 891
2022
Q3 		$6.22M Buy
+132,502
New +$6.31M 0.01% 1838

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

D.E. Shaw & Co's IMCR Position: Q1 2026 in Review

D.E. Shaw & Co increased its Immunocore (IMCR) stake by 82% in Q1 2026, buying an estimated $4.89M and bringing the position to 335,191 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #1636.

D.E. Shaw & Co first reported a position in IMCR in Q3 2022 and has held it in 10 quarters since. The position peaked at $20.7M in Q4 2022. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • D.E. Shaw & Co held 335,191 shares of Immunocore worth $10.1M as of Q1 2026.
  • D.E. Shaw & Co bought 151,251 Immunocore shares in Q1 2026, an estimated $4.89M.
  • Immunocore made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1636 holding.
  • D.E. Shaw & Co first reported a position in Immunocore in Q3 2022 and has held it in 10 quarters since.
  • D.E. Shaw & Co's Immunocore position peaked at $20.7M in Q4 2022.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.